Miconazole
Classification: BATC code: D01AC02, D01AC20
Summary
A large amount of the studies consider treatment of vaginal infections, therefore analyses on sex or gender differences are lacking.
The present evidence concerning differences between men and women is very limited due to the indication of the substance but does not motivate differentiation in dosing or treatment.
Additional information
Pharmacokinetics and dosing
No difference between men and women has been shown for transdermal absorption in general [1].
Effects
No studies with a clinically relevant sex analysis regarding effects of mikonazol have been found.
Adverse effects
No studies with a clinically relevant sex analysis regarding adverse effects of mikonazol have been found.
Reproductive health issues
Regarding teratogenic aspects, please consult Janusmed Drugs and Birth Defects (in Swedish, Janusmed fosterpåverkan).
Updated: 2020-08-28
Date of litterature search: 2017-02-21
Reviewed by: Mia von Euler
Approved by: Karin Schenck-Gustafsson